Guru Reddy, Ph.D.

Vice President of Preclinical R&D

Guru Reddy, Ph.D., joined Unicycive in 2022 as Vice President of Preclinical R&D. Dr. Reddy has over 25 years of R&D experience in the biopharmaceutical industry. Prior to joining Unicycive, he worked at Spectrum Pharmaceuticals for 15 years, where he held R&D roles with increasing responsibilities serving most recently as the Vice President of Preclinical R&D. At Spectrum Pharmaceuticals, he was responsible for the preclinical development and clinical pharmacology of a large product pipeline culminating in multiple NDA submissions and full regulatory approval of 4 drugs from the US FDA.

Dr. Reddy has a wide range of experience in drug development, including preclinical research & development, early clinical development, and regulatory strategy.

Dr. Reddy earned his PhD in biochemistry from the University of Poona/National Chemical Laboratory in India and obtained his post-doctoral training at Yale University. He is an inventor on 17 granted US patents and has co-authored over 30 peer-reviewed publications.